Introduction
Obesity is a major pathologic condition which represents an important risk factor for Type 2 diabetes and cardiovascular diseases. The discovery of ob gene and its transcript by the group of Friedmann 1 and of the new uncoupling proteins UCP2 and UCP3 2, 3 widely expressed in different tissues in both animals and humans led us to reconsider the control system of energy balance in obesity. Leptin clearly represents the peripheral satiating factor, signaling to the brain the amount of energy stored in the body according to the lypostatic model. However the role of the new uncouplers on the energy homeostasis is still controversial. In particular, the effect of food restriction and refeeding on UCP3 expression and its relationship with leptin changes are not fully understood. The aim of this study was therefore to investigate the effect of food restriction and refeeding on plasma leptin levels and on the expression of UCP3 in both lean and obese Zucker rats.
Material and methods
We studied 12 lean and 12 genetically obese ( faafa) Zucker rats. The animals were housed in our animal quarter with a 12 h light cycle and had free access to water and to an animal standard chow (Zoopharma, Padova, Italy) until the beginning of the study protocol.
The animals underwent a program of food restriction (40% of basal food consumption) to reduce body weight by about 20%; thereafter the animals had free access to food to gain initial body weight. A control group of animals were fed ad libitum. Blood samples were collected before food restriction, at the maximal weight loss, during the refeeding phase and at the end of the study. Plasma insulin, FFA, glycerol and leptin were measured. Different groups of animals were killed at the baseline, at the end of the weight loss (NADIR of weight), at 50% weight recovery and at complete weight recovery. UCP3 mRNA signal was measured on the tibial muscle of each rat by Northern blot hybridization.
Analytic methods
NEFA levels were measured in plasma with enzymatic-spectrophotometric methods using a commercial kit (Boehringer Mannheim, Mannheim, Germany). Plasma glucose was measured with the glucose oxidase method on a Beckman glucose analyzer 2 (Beckman Instruments Inc., Fullerton, CA, USA). Insulin was measured by radioimmunoassay with an antibody raised against rat insulin and rat insulin as tracer and standard (Linco Research Inc., St Charles, MO, USA). Glycerol was measured on plasma, after deproteinization with percloric acid, by enzymatic spectrophotometric technique (Boehringer Mannheim, Mannheim, Germany). Plasma leptin was measured by a speci®c radioimmunoassay (Linco Research Inc., St Charles, MO, USA). The components of the kit included recombinant mouse leptin as standards, radioiodinated recombinant mouse leptin, rabbit antiserum against mouse leptin and quality control pools.
Northern blot
Total RNA was prepared by the method of Chomczynski and Sacchi 4 with guanidinium isothiocyanate phenol chlorophorm. RNA was quanti®ed spectrophotometrically at 260 nm and a quantity of 20 mg per lane was loaded on a 0.8% agarose gel containing 37% formaldehyde; electrophoresis was performed at 120 V for 5 h.
RNA was then transferred to a nylon membrane (Hybond-N, Amersham) overnight and crosslinked to membranes by ultraviolet irradiation for 5 min. The blots were prehybridized for 3 h at 65 C in a phosphate buffer pH 6.8, containing BSA 1%, SDS 7%, EDTA 1 mM. Hybridization was performed at 65 C with a cDNA fragment of UCP3 that was [ 32 P]-labeled by random priming (Amersham Corp., Les Ulis, France); the blots were then washed twice for 15 min at 65 C in a solution of 2SSC (1 SSC is 150 mM NaCl, 15 mM sodium citrate, pH 7.0a0.1 sodium dodecyl sulphate) and exposed (Kodak Bio Max Film) at À80 C with intensifying screen. The signals on the autoradiograms were quanti®ed by scanning densitometry. Hybridization of the blots with a [ 32 P] ATPlabeled b actin was used to correct for differences in the amounts of RNA loaded onto the gel.
Results and discussion
In our experiments we observed a different pattern in the weight variations during the study protocol in the two groups of animals: the weight loss is more rapid in lean animals than in obese (1.5% daily vs 0.7% daily); during the refeeding phase there is an early period, where food intake is very intense, of quick weight gain, and a second, where the increase is more gradual.
Our results show that the weight reduction produced a signi®cant increase of plasma glycerol ( 30%) both in lean and in obese animals, indicating a comparable stimulation of lipolysis. Plasma FFA were increased by food restriction in lean animals (basal vs NADIR: 1.19 AE 0.18 mmolaL vs 1.84 AE 0.19 mmolaL; P`0.05) while they were reduced in obese animals (basal vs NADIR: 1.91 AE 0.63 vs 1.43 AE 0.27 mmolaL; P`0.05). Plasma leptin was signi®cantly reduced by weight loss in lean rats (basal vs NADIR: 1.35 AE 0.3 vs 0.66AE 0.1 ngaml; P`0.001) and returned to baseline levels when only 50% of weight was recovered. In contrast no changes in plasma leptin were found in obese rats both at the end of weight loss and during the refeeding phase.
As shown in Figure 1 UCP3 mRNA expression was unchanged by food restriction both in lean and obese rats. In contrast UCP3 expression was increased ®ve-fold in tibialis muscle of obese animals during the early recovery period, when food consumption was maximally increased, and returned to baseline levels at the complete recovery.
In our study we ®nd a very different regulation pattern of UCP3 mRNA expression in lean and obese rats during the early refeeding phase. This difference does not seem to be related to FFA levels, as reported by other authors. 5 In the obese animals a marked increase in UCP3 expression was observed in the early refeeding phase, while this phenomenon was not present in lean rats. In lean rats leptin release from adipose tissue resulted strongly stimulated in the early refeeding phase, while this was not the case in obese rats.
The reduction in the expression of UCP3 we observe in the lean rats during the early refeeding phase may be related to the necessity to recover body weight, minimizing the energy dissipation and increasing the intake of energetic substrates. Moreover the increase of leptin levels should constitute a feedback mechanism to avoid an excessive weight gain. On the contrary in faafa rat, where a defective leptin action at the CNS level exists, UCP3 overexpression could constitute a compensatory event in order to attempt to prevent an excessive weight gain. At present this hypothesis seems to be highly speculative, as we have not yet a de®nitive information on the role of UCP3 in peripheral energy control.
